Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Dec;10(6):878–884. doi: 10.1128/aac.10.6.878

In Vitro Activity of Gentamicin, Amikacin, and Netilmicin Alone and in Combination with Carbenicillin Against Serratia marcescens

Steven M Pogwizd 1, Stephen A Lerner 1
PMCID: PMC429858  PMID: 795373

Abstract

The inhibitory and bactericidal effects of gentamicin, amikacin, netilmicin (Sch 20569), and carbenicillin were tested against 55 clinical isolates of Serratia marcescens that had been subtyped into 26 strains by biotyping and serotyping. Three major patterns of resistance to gentamicin, netilmicin, and carbenicillin were recognized among these isolates. (i) Most of the 27 isolates that were susceptible to gentamicin (minimal bactericidal concentration [MBC] ≤6.25 μg/ml) were susceptible to carbenicillin (MBC ≤125 μg/ml) and resistant to netilmicin (MBC ≥12.5 μg/ml). (ii) Most of the 11 isolates with moderate resistance to gentamicin (MBC of 12.5 to 25 μg/ml) were also susceptible to carbenicillin and resistant to netilmicin. (iii) The 17 isolates with high-level resistance to gentamicin (MBC ≥ 50 μg/ml) were all highly resistant to carbenicillin (MBC ≥8,000 μg/ml) but susceptible to netilmicin (MBC ≤6.25 μg/ml). The susceptibility to amikacin was unpredictable among these groups of isolates but, overall, 80% of the isolates were killed by 25 μg of amikacin/ml, which is within the range of peak serum concentrations used therapeutically. Clinically attainable subinhibitory concentrations of carbenicillin enhanced the activity of the three aminoglycosides against all isolates with MBCs of carbenicillin ≤2,000 μg/ml. The 17 isolates with high-level resistance to carbenicillin and gentamicin, as well as the four isolates with high-level resistance to carbenicillin but not to gentamicin, were not susceptible to such enhancement of aminoglycoside activity by carbenicillin.

Full text

PDF
881

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. L., Gramling P. K., Vestal P. R., Farrar W. E., Jr Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Antimicrob Agents Chemother. 1975 Sep;8(3):300–304. doi: 10.1128/aac.8.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andriole V. T. Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J Infect Dis. 1974 Feb;129(2):124–133. doi: 10.1093/infdis/129.2.124. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Stewart D. In vitro studies of BB-K8, a new aminoglycoside antibiotic. Antimicrob Agents Chemother. 1973 Aug;4(2):186–192. doi: 10.1128/aac.4.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Britt M. R., Garibaldi R. A., Wilfert J. N., Smith C. B. In vitro activity of tobramycin and gentamicin. Antimicrob Agents Chemother. 1972 Sep;2(3):236–241. doi: 10.1128/aac.2.3.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bryan C. S., Marney S. R., Jr, Alford R. H., Bryant R. E. Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test. Am J Med. 1975 Feb;58(2):209–215. doi: 10.1016/0002-9343(75)90571-9. [DOI] [PubMed] [Google Scholar]
  6. Farhoudi H. O., Banks T., Ali N. A case report of serratia endocarditis with review of the literature. Med Ann Dist Columbia. 1974 Aug;43(8):401–406. [PubMed] [Google Scholar]
  7. Greenup P., Blazevic D. J. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens. Appl Microbiol. 1971 Sep;22(3):309–314. doi: 10.1128/am.22.3.309-314.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harris J. A., Cobbs C. G. Serratia endocarditis in patients with a Starr-Edwards valve: report of a case of bacteriologic cure with antimicrobial therapy. South Med J. 1973 Oct;66(10):1117–1120. doi: 10.1097/00007611-197310000-00008. [DOI] [PubMed] [Google Scholar]
  9. Howard J. B., McCracken G. H., Jr Pharmacological evaluation of amikacin in neonates. Antimicrob Agents Chemother. 1975 Jul;8(1):86–90. doi: 10.1128/aac.8.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hyams P. J., Simberkoff M. S., Rahal J. J., Jr In vitro bactericidal effectiveness of four aminoglycoside antibiotics. Antimicrob Agents Chemother. 1973 Jan;3(1):87–94. doi: 10.1128/aac.3.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Klastersky J., Cappel R., Daneau D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother. 1972 Dec;2(6):470–475. doi: 10.1128/aac.2.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Klastersky J., Cappel R., Daneau D. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer. 1973 Feb;31(2):331–336. doi: 10.1002/1097-0142(197302)31:2<331::aid-cncr2820310210>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  13. Klastersky J., Swings G., Daneau D. Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli. Am J Med Sci. 1970 Dec;260(6):373–380. doi: 10.1097/00000441-197012000-00006. [DOI] [PubMed] [Google Scholar]
  14. Kluge R. M., Standiford H. C., Tatem B., Young V. M., Greene W. H., Schimpff S. C., Calia F. M., Hornick R. B. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1974 Oct;6(4):442–446. doi: 10.1128/aac.6.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kluge R. M., Standiford H. C., Tatem B., Young V. M., Schimpff S. C., Greene W. H., Calia F. M., Hornick R. B. The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Ann Intern Med. 1974 Nov;81(5):584–587. doi: 10.7326/0003-4819-81-5-584. [DOI] [PubMed] [Google Scholar]
  16. Levison M. E., Kaye D. In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8. Antimicrob Agents Chemother. 1974 Jun;5(6):667–669. doi: 10.1128/aac.5.6.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Maki D. G., Hennekens C. G., Phillips C. W., Shaw W. V., Bennett J. V. Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis. 1973 Nov;128(5):579–587. doi: 10.1093/infdis/128.5.579. [DOI] [PubMed] [Google Scholar]
  18. Meyer R. D., Lewis R. P., Carmalt E. D., Finegold S. M. Amikacin therapy for serious gram-negative bacillary infections. Ann Intern Med. 1975 Dec;83(6):790–800. doi: 10.7326/0003-4819-83-6-790. [DOI] [PubMed] [Google Scholar]
  19. Meyers B. R., Leng B., Hirschman S. Z. Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria. Antimicrob Agents Chemother. 1975 Dec;8(6):757–758. doi: 10.1128/aac.8.6.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mills J., Drew D. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med. 1976 Jan;84(1):29–35. doi: 10.7326/0003-4819-84-1-29. [DOI] [PubMed] [Google Scholar]
  21. Myerowitz R. L., Medeiros A. A., O'Brien T. F. Recent experience with bacillemia due to gram-negative organisms. J Infect Dis. 1971 Sep;124(3):239–246. doi: 10.1093/infdis/124.3.239. [DOI] [PubMed] [Google Scholar]
  22. Phair J. P., Watanakunakorn C., Bannister T. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl Microbiol. 1969 Sep;18(3):303–306. doi: 10.1128/am.18.3.303-306.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Price K. E., Pursiano T. A., DeFuria M. D. Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics. Antimicrob Agents Chemother. 1974 Feb;5(2):143–152. doi: 10.1128/aac.5.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Roemisch E., Kocka F. E. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens. Am J Clin Pathol. 1976 Jul;66(1):96–100. doi: 10.1093/ajcp/66.1.96. [DOI] [PubMed] [Google Scholar]
  26. Sanford J. P. Sensitivity tests of klebsiella, enterobacter, and serratia. J Infect Dis. 1969 Apr-May;119(4):388–390. doi: 10.1093/infdis/119.4-5.388. [DOI] [PubMed] [Google Scholar]
  27. Schimpff S., Satterlee W., Young V. M., Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med. 1971 May 13;284(19):1061–1065. doi: 10.1056/NEJM197105132841904. [DOI] [PubMed] [Google Scholar]
  28. Smith C. B., Dans P. E., Wilfert J. N., Finland M. Use of gentamicin in combinations with other antibiotics. J Infect Dis. 1969 Apr-May;119(4):370–377. doi: 10.1093/infdis/119.4-5.370. [DOI] [PubMed] [Google Scholar]
  29. Sonne M., Jawetz E. Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro. Appl Microbiol. 1969 Jun;17(6):893–896. doi: 10.1128/am.17.6.893-896.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tally F. P., Louie T. J., Weinstein W. M., Bartlett J. G., Gorbach S. L. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. Ann Intern Med. 1975 Oct;83(4):484–488. doi: 10.7326/0003-4819-83-4-484. [DOI] [PubMed] [Google Scholar]
  31. Thomas F. E., Jr, Leonard J. M., Alford R. H. Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections. Antimicrob Agents Chemother. 1976 Feb;9(2):201–207. doi: 10.1128/aac.9.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Thornton G. F., Andriole V. T. Antibiotic sensitivities of nonpigmented serratia marcescens to gentamicin and carbenicillin. J Infect Dis. 1969 Apr-May;119(4):393–394. doi: 10.1093/infdis/119.4-5.393. [DOI] [PubMed] [Google Scholar]
  33. Wald E. R., Standiford H. C., Tatem B. A., Calia F. M., Hornick R. B. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1975 Mar;7(3):336–340. doi: 10.1128/aac.7.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weinstein R. J., Young L. S., Hewitt W. L. Activity of three aminoglycosides and two penicillins against four species of gram-negative bacilli. Antimicrob Agents Chemother. 1975 Feb;7(2):172–178. doi: 10.1128/aac.7.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weinstein R. J., Young L. S., Hewitt W. L. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia. J Lab Clin Med. 1975 Nov;86(5):853–862. [PubMed] [Google Scholar]
  36. Wilfert J. N., Barrett F. F., Ewing W. H., Finland M., Kass E. H. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol. 1970 Feb;19(2):345–352. doi: 10.1128/am.19.2.345-352.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wilfert J. N., Barrett F. F., Kass E. H. Bacteremia due to serratia marcescens. N Engl J Med. 1968 Aug 8;279(6):286–289. doi: 10.1056/NEJM196808082790604. [DOI] [PubMed] [Google Scholar]
  38. Young L. S., Hewitt W. L. Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus. Antimicrob Agents Chemother. 1973 Dec;4(6):617–625. doi: 10.1128/aac.4.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yu P. K., Washington J. A., 2nd Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin. Antimicrob Agents Chemother. 1973 Aug;4(2):133–139. doi: 10.1128/aac.4.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yu P. K., Washington J. A., 2nd Comparison of in vitro antibacterial activities of gentamicin and verdamicin. Antimicrob Agents Chemother. 1974 Oct;6(4):526–528. doi: 10.1128/aac.6.4.526. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES